The nitric oxide redox sibling nitroxyl partially circumvents impairment of platelet nitric oxide responsiveness

Nitric Oxide - Biology and Chemistry

Volumn 35, Issue , 2013, Pages 72-78

  Dautov, R F ^a   Ngo, D T M ^a   Licari, G ^a   Liu, S ^a   Sverdlov, A L ^a   Ritchie, R H ^b   Kemp Harper, B K ^c   Horowitz, J D ^a   Chirkov, Y Y ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

cGMP; Isopropylamine NONOate; Nitric oxide; Nitroxyl; NO resistance; Platelet aggregation

Indexed keywords

ANTITHROMBOCYTIC AGENT; CYCLIC GMP; ISOPROPYLAMINE NONOATE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VASODILATOR AGENT; 1-ISOPROPYLDIAZEN-1-IUM-1,2-DIOLATE; HYDRAZINE DERIVATIVE; NITRIC OXIDE; NITROGEN OXIDE; NITROXYL;

AGED; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; DRUG POTENCY; FEMALE; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; CASE CONTROL STUDY; DRUG EFFECTS; HEART MUSCLE ISCHEMIA; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; THROMBOCYTE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD PLATELETS; CASE-CONTROL STUDIES; CYCLIC GMP; FEMALE; HUMANS; HYDRAZINES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NITRIC OXIDE; NITROGEN OXIDES; NITROPRUSSIDE; OXIDATION-REDUCTION; PLATELET AGGREGATION;

EID: 84883889139     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2013.08.006     Document Type: Article

References (52)

1. S.M. Lohmann, and U. Walter Tracking functions of cGMP-dependent protein kinases (cGK) Front. Biosci. 10 2005 1313 1328
2. Y.Y. Chirkov, A.S. Holmes, S.R. Willoughby, S. Stewart, R.D. Wuttke, P.R. Sage, and J.D. Horowitz Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets J. Am. Coll. Cardiol. 37 2001 1851 1857 (Pubitemid 32499970)
3. Y.Y. Chirkov, and J.D. Horowitz Impaired tissue responsiveness to organic nitrates and nitric oxide: a new therapeutic frontier? Pharmacol. Ther. 116 2007 287 305 (Pubitemid 47451509)
4. Y.Y. Chirkov, L.P. Chirkova, and J.D. Horowitz Suppressed anti-aggregating and cGMP-elevating effects of sodium nitroprusside in platelets from patients with stable angina pectoris Naunyn Schmiedebergs Arch. Pharmacol. 354 1996 520 525 (Pubitemid 26327128)
5. Y.Y. Chirkov, A.S. Holmes, L.P. Chirkova, and J.D. Horowitz Nitrate resistance in platelets from patients with stable angina pectoris Circulation 100 1999 129 134 (Pubitemid 29330010)
6. Y.Y. Chirkov, A.S. Holmes, J.D. Martelli, and J.D. Horowitz Effect of perindopril on platelet nitric oxide resistance in patients with chronic heart failure secondary to ischemic left ventricular dysfunction Am. J. Cardiol. 93 2004 1438 1440 A10 (Pubitemid 38692483)
7. V. Schachinger, M.B. Britten, and A.M. Zeiher Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease Circulation 101 2000 1899 1906 (Pubitemid 30225269)
8. S.R. Willoughby, S. Stewart, A.S. Holmes, Y.Y. Chirkov, and J.D. Horowitz Platelet nitric oxide responsiveness: a novel prognostic marker in acute coronary syndromes Arterioscler. Thromb. Vasc. Biol. 25 2005 2661 2666 (Pubitemid 43732294)
9. S.R. Willoughby, S. Rajendran, W.P. Chan, N. Procter, S. Leslie, E.A. Liberts, T. Heresztyn, Y.Y. Chirkov, and J.D. Horowitz Ramipril sensitizes platelets to nitric oxide: implications for therapy in high-risk patients J. Am. Coll. Cardiol. 60 2012 887 894
10. S.R. Willoughby, S. Stewart, Y.Y. Chirkov, J.A. Kennedy, A.S. Holmes, and J.D. Horowitz Beneficial clinical effects of perhexiline in patients with stable angina pectoris and acute coronary syndromes are associated with potentiation of platelet responsiveness to nitric oxide Eur. Heart J. 23 2002 1946 1954 (Pubitemid 35448553)
11. A. Ellis, C.G. Li, and M.J. Rand Differential actions of l-cysteine on responses to nitric oxide, nitroxyl anions and EDRF in the rat aorta Br. J. Pharmacol. 129 2000 315 322 (Pubitemid 30072652)
12. J.C. Wanstall, T.K. Jeffery, A. Gambino, F. Lovren, and C.R. Triggle Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion Br. J. Pharmacol. 134 2001 463 472 (Pubitemid 32977891)
13. E. Bermejo, D.A. Saenz, F. Alberto, R.E. Rosenstein, S.E. Bari, and M.A. Lazzari Effect of nitroxyl on human platelets function Thromb. Haemost. 94 2005 578 584 (Pubitemid 41300855)
14. J.C. Irvine, J.L. Favaloro, and B.K. Kemp-Harper NO-activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries Hypertension 41 2003 1301 1307 (Pubitemid 36706081)
15. T.W. Miller, M.M. Cherney, A.J. Lee, N.E. Francoleon, P.J. Farmer, S.B. King, A.J. Hobbs, K.M. Miranda, J.N. Burstyn, and J.M. Fukuto The effects of nitroxyl (HNO) on soluble guanylate cyclase activity: interactions at ferrous heme and cysteine thiols J. Biol. Chem. 284 2009 21788 21796
16. N. Paolocci, T. Katori, H.C. Champion, M.E. St John, K.M. Miranda, J.M. Fukuto, D.A. Wink, and D.A. Kass Positive inotropic and lusitropic effects of HNO/NO-in failing hearts: independence from beta-adrenergic signaling Proc. Natl. Acad. Sci. USA 100 2003 5537 5542 (Pubitemid 36542740)
17. N. Paolocci, W.F. Saavedra, K.M. Miranda, C. Martignani, T. Isoda, J.M. Hare, M.G. Espey, J.M. Fukuto, M. Feelisch, D.A. Wink, and D.A. Kass Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling Proc. Natl. Acad. Sci. USA 98 2001 10463 10468 (Pubitemid 32803042)
18. â̂ - and beyond Pharmacol. Ther. 124 2009 279 300
19. 2+ cycling Circ. Res. 100 2007 96 104 (Pubitemid 46066777)
20. E.Q. Lin, J.C. Irvine, A.H. Cao, A.E. Alexander, J.E. Love, R. Patel, J.R. McMullen, D.M. Kaye, B.K. Kemp-Harper, and R.H. Ritchie Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation PLoS One 7 2012 e34892
21. A.A. Miller, K.F. Maxwell, S. Chrissobolis, M.L. Bullen, J.M. Ku, T. Michael De Silva, S. Selemidis, E.U. Hooker, G.R. Drummond, C.G. Sobey, and B.K. Kemp-Harper Nitroxyl (HNO) suppresses vascular Nox2 oxidase activity Free Radic. Biol. Med. 60 2013 264 271
22. M.L. Bullen, A.A. Miller, J. Dharmarajah, G.R. Drummond, C.G. Sobey, and B.K. Kemp-Harper Vasorelaxant and antiaggregatory actions of the nitroxyl donor isopropylamine NONOate are maintained in hypercholesterolemia Am. J. Physiol. Heart Circ. Physiol. 301 2011 H1405 H1414
23. C.H. Leo, A. Joshi, J.L. Hart, and O.L. Woodman Endothelium-dependent nitroxyl-mediated relaxation is resistant to superoxide anion scavenging and preserved in diabetic rat aorta Pharmacol. Res. 66 2012 383 391
24. B.M. Wynne, H. Labazi, R.C. Tostes, and R.C. Webb Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses Pharmacol. Res. 65 2012 41 47
25. J.C. Irvine, B.K. Kemp-Harper, and R.E. Widdop Chronic administration of the HNO donor Angeli's salt does not lead to tolerance, cross-tolerance, or endothelial dysfunction: comparison with GTN and DEA/NO Antioxid. Redox Signal. 14 2011 1615 1624
26. T. Akaike, M. Yoshida, Y. Miyamoto, K. Sato, M. Kohno, K. Sasamoto, K. Miyazaki, S. Ueda, and H. Maeda Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/NO through a radical reaction Biochemistry 32 1993 827 832 (Pubitemid 23059363)
27. -) using l-cysteine Biochem. Biophys. Res. Commun. 201 1994 54 62
28. J. Garthwaite, E. Southam, C.L. Boulton, E.B. Nielsen, K. Schmidt, and B. Mayer Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one Mol. Pharmacol. 48 1995 184 188
29. N. Sogo, K.S. Magid, C.A. Shaw, D.J. Webb, and I.L. Megson Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms Biochem. Biophys. Res. Commun. 279 2000 412 419 (Pubitemid 32036706)
30. R.L. Kinlough-Rathbone, M.A. Packham, and J.F. Mustard Platelet aggregation Z.T. Harker, Measurements of Platelet Function 1983 Churchill Livingstone New York 64 91
31. C.M. Maragos, D. Morley, D.A. Wink, T.M. Dunams, J.E. Saavedra, A. Hoffman, A.A. Bove, L. Isaac, J.A. Hrabie, and L.K. Keefer Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects J. Med. Chem. 34 1991 3242 3247
32. N. Mariappan, C.M. Elks, B. Fink, and J. Francis TNF-induced mitochondrial damage: a link between mitochondrial complex I activity and left ventricular dysfunction Free Radic. Biol. Med. 46 2009 462 470
33. K.M. Miranda, T. Katori, C.L. Torres de Holding, L. Thomas, L.A. Ridnour, W.J. McLendon, S.M. Cologna, A.S. Dutton, H.C. Champion, D. Mancardi, C.G. Tocchetti, J.E. Saavedra, L.K. Keefer, K.N. Houk, J.M. Fukuto, D.A. Kass, N. Paolocci, and D.A. Wink Comparison of the NO and HNO donating properties of diazeniumdiolates: primary amine adducts release HNO in vivo J. Med. Chem. 48 2005 8220 8228 (Pubitemid 43032530)
34. D.J. Salmon, C.L. Torres de Holding, L. Thomas, K.V. Peterson, G.P. Goodman, J.E. Saavedra, A. Srinivasan, K.M. Davies, L.K. Keefer, and K.M. Miranda HNO and NO release from a primary amine-based diazeniumdiolate as a function of pH Inorg. Chem. 50 2011 3262 3270
35. M.L. Bullen, A.A. Miller, K.L. Andrews, J.C. Irvine, R.H. Ritchie, C.G. Sobey, and B.K. Kemp-Harper Nitroxyl (HNO) as a vasoprotective signaling molecule Antioxid. Redox Signal. 14 2011 1675 1686
36. M.L. Bullen, A.A. Miller, G.R. Drummond, C.G. Sobey, J. Stasch, Y.Y. Chirkov, J.D. Horowitz, and B.K. Kemp-Harper Nitric oxide-independent stimulators of soluble guanylyl cyclase circumvent platelet nitric oxide resistance in hypercholesterolemic mice Circulation 2012 A15855
37. P.W. Armstrong, J.A. Armstrong, and G.S. Marks Pharmacokinetic- hemodynamic studies of intravenous nitroglycerin in congestive cardiac failure Circulation 62 1980 160 166 (Pubitemid 10083110)
38. A.R. Maher, S. Arif, M. Madhani, K. Abozguia, I. Ahmed, B.O. Fernandez, M. Feelisch, A. O'Sullivan, A. Christopoulos, A.L. Sverdlov, D. Ngo, R. Dautov, P.E. James, J.D. Horowitz, and M.P. Frenneaux Impact of chronic congestive heart failure on pharmacokinetics and vasomotor effects of infused nitrite Br. J. Pharmacol. 169 2013 659 670
39. M.I. Worthley, A.S. Holmes, S.R. Willoughby, A.M. Kucia, T. Heresztyn, S. Stewart, Y.Y. Chirkov, C.J. Zeitz, and J.D. Horowitz The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration J. Am. Coll. Cardiol. 49 2007 304 310 (Pubitemid 46097375)
40. J.M. Stepien, R.M. Prideaux, S.R. Willoughby, Y.Y. Chirkov, and J.D. Horowitz Pilot study examining the effect of cholesterol lowering on platelet nitric oxide responsiveness and arterial stiffness in subjects with isolated mild hypercholesterolaemia Clin. Exp. Pharmacol. Physiol. 30 2003 507 512 (Pubitemid 36836570)
41. K.M. Miranda, N. Paolocci, T. Katori, D.D. Thomas, E. Ford, M.D. Bartberger, M.G. Espey, D.A. Kass, M. Feelisch, J.M. Fukuto, and D.A. Wink A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system Proc. Natl. Acad. Sci. USA 100 2003 9196 9201 (Pubitemid 37033906)
42. J.M. Fukuto, C.J. Cisneros, and R.L. Kinkade A comparison of the chemistry associated with the biological signaling and actions of nitroxyl (HNO) and nitric oxide (NO) J. Inorg. Biochem. 118 2013 201 208
43. N.B. Fernhoff, E.R. Derbyshire, and M.A. Marletta A nitric oxide/cysteine interaction mediates the activation of soluble guanylate cyclase Proc. Natl. Acad. Sci. USA 106 2009 21602 21607
44. N.B. Fernhoff, E.R. Derbyshire, E.S. Underbakke, and M.A. Marletta Heme-assisted S-nitrosation desensitizes ferric soluble guanylate cyclase to nitric oxide J. Biol. Chem. 287 2012 43053 43062
45. A. Zeller, M.V. Wenzl, M. Beretta, H. Stessel, M. Russwurm, D. Koesling, K. Schmidt, and B. Mayer Mechanisms underlying activation of soluble guanylate cyclase by the nitroxyl donor Angeli's salt Mol. Pharmacol. 76 2009 1115 1122
46. K.M. Miranda, R.W. Nims, D.D. Thomas, M.G. Espey, D. Citrin, M.D. Bartberger, N. Paolocci, J.M. Fukuto, M. Feelisch, and D.A. Wink Comparison of the reactivity of nitric oxide and nitroxyl with heme proteins. A chemical discussion of the differential biological effects of these redox related products of NOS J. Inorg. Biochem. 93 2003 52 60 (Pubitemid 36132133)
47. J.M. Fukuto, and S.J. Carrington HNO signaling mechanisms Antioxid. Redox Signal. 14 2011 1649 1657
48. B.E. Lopez, M. Shinyashiki, T.H. Han, and J.M. Fukuto Antioxidant actions of nitroxyl (HNO) Free Radic. Biol. Med. 42 2007 482 491 (Pubitemid 46162118)
49. H.H. Schmidt, P.M. Schmidt, and J.P. Stasch NO- and haem-independent soluble guanylate cyclase activators Handb. Exp. Pharmacol. 2009 309 339
50. C.G. Tocchetti, B.A. Stanley, C.I. Murray, V. Sivakumaran, S. Donzelli, D. Mancardi, P. Pagliaro, W.D. Gao, J. van Eyk, D.A. Kass, D.A. Wink, and N. Paolocci Playing with cardiac "redox switches": the "HNO way" to modulate cardiac function Antioxid. Redox Signal. 14 2011 1687 1698
51. J.F. DuMond, M.W. Wright, and S.B. King Water soluble acyloxy nitroso compounds: HNO release and reactions with heme and thiol containing proteins J. Inorg. Biochem. 118 2013 140 147
52. M.E. Shoman, J.F. DuMond, T.S. Isbell, J.H. Crawford, A. Brandon, J. Honovar, D.A. Vitturi, C.R. White, R.P. Patel, and S.B. King Acyloxy nitroso compounds as nitroxyl (HNO) donors: kinetics, reactions with thiols, and vasodilation properties J. Med. Chem. 54 2011 1059 1070